Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DNK | Ann:Issue of Unlisted Options | 12/06/25 | 0 | 357 | |||
|
|||||||
DNK | Ann:Change in Director's Interests - Seamus Cornelius | 12/06/25 | 0 | 314 | |||
|
|||||||
DNK | Ann:Results of Annual General Meeting | 30/05/25 | 0 | 380 | |||
|
|||||||
DNK | Ann:Replacement Constitution | 30/05/25 | 0 | 430 | |||
|
|||||||
DNK | Ann:Withdrawal of AGM Resolution | 30/05/25 | 3 | 1.3K | |||
|
|||||||
DNK | Ann:Quarterly Activities and Cashflow Report (Price Sensitive) | 02/05/25 | 3 | 1.7K | |||
|
|||||||
DNK | Ann:Notice of Annual General Meeting | 01/05/25 | 0 | 423 | |||
|
|||||||
DNK | Ann:Results of Unmarketable Parcel Share Buy-back | 09/04/25 | 0 | 472 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |